87
Participants
Start Date
March 8, 2022
Primary Completion Date
November 8, 2027
Study Completion Date
November 8, 2027
ZX008 (Fenfluramine Hydrochloride)
ZX008 is supplied as an oral aqueous solution of Fenfluramine Hydrochloride.
Matching ZX008 Placebo
Matching ZX008 placebo is supplied as an oral solution.
Ep0216 120, Philadelphia
Ep0216 149, Washington D.C.
Ep0216 166, Chapel Hill
Ep0216 157, Atlanta
Ep0216 154, Birmingham
Ep0216 124, Memphis
Ep0216 164, Cleveland
Ep0216 134, Detroit
Ep0216 171, Austin
Ep0216 173, Aurora
Ep0216 144, Los Angeles
Ep0216 101, San Francisco
Ep0216 113, Boston
Ep0216 2505, Linz
Ep0216 804, Brussels
Ep0216 801, Edegem
Ep0216 2802, Tbilisi
Ep0216 902, Bielefeld
Ep0216 909, Kehl-Kork
Ep0216 908, Kiel
Ep0216 901, Vogtareuth
Ep0216 1803, Dublin
Ep0216 1909, Petah Tikva
Ep0216 1906, Ramat Gan
Ep0216 1904, Tel Aviv
Ep0216 1201, Florence
Ep0216 1204, Genova
Ep0216 1212, Modena
Ep0216 1206, Roma
Ep0216 1208, Roma
Ep0216 1202, Verona
Ep0216 1512, Hiroshima
Ep0216 1505, Niigata
Ep0216 1518, Ōmura
Ep0216 1502, Shizuoka
Ep0216 1401, Zwolle
Ep0216 2104, Lisbon
Ep0216 2105, Porto
Ep0216 1103, Barcelona
Ep0216 1117, Madrid
Ep0216 1118, Santiago de Compostela
Ep0216 3101, Dubai
Ep0216 607, Bristol
Ep0216 602, London
Ep0216 611, Manchester
Ep0216 604, Sheffield
Zogenix, Inc.
INDUSTRY